E4CPG - CAS 170846-89-6
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C11H13NO4
Molecular Weight:
223.23
COA:
Inquire
Targets:
mGluR
Description:
E4CPG is a group I/group II metabotropic glutamate receptor antagonist with higher potency than (RS)-MCPG.
Brife Description:
group I/II mGluR antagonist
Purity:
≥99% by HPLC
Synonyms:
(RS)-α-Ethyl-4-carboxyphenylglycine; 4-(1-amino-1-carboxypropyl)benzoic acid
MSDS:
Inquire
InChIKey:
AIEFWRHRHFRLFT-UHFFFAOYSA-N
InChI:
InChI=1S/C11H13NO4/c1-2-11(12,10(15)16)8-5-3-7(4-6-8)9(13)14/h3-6H,2,12H2,1H3,(H,13,14)(H,15,16)
Canonical SMILES:
CCC(C1=CC=C(C=C1)C(=O)O)(C(=O)O)N
1.Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw.
Beirith A;Santos AR;Calixto JB Brain Res. 2002 Jan 11;924(2):219-28.
This study characterizes the receptor subtypes and investigates some of the mechanisms by which glutamate, injected intraplantarly (i.pl.) into the mouse paw, produces nociception and paw oedema. I.pl. injection of glutamate induced a rapid-onset, dose-related pain response associated with oedema formation, with mean ED(50) values of 2.6 (1.6-4.3) and 0.5 (0.4-0.7) micromol/kg, respectively. Pretreatment with Chicago sky blue 6B (100 microg/kg), an inhibitor of glutamate uptake, caused a significant (about sixfold) reduction of the mean ED(50) value for glutamate-induced nociception, but not paw oedema. NMDA receptor antagonist MK 801, given by systemic (i.p.), intracerebroventricular (i.c.v.), i.pl. or intrathecal (i.t.) routes, produced graded inhibition of glutamate-induced nociception. Non-NMDA receptor antagonists NBQX or GAMS, metabotropic antagonist E4CPG, and also the antagonist that acts at the NMDA receptor-associated glycine binding site felbamate, significantly inhibited the nociception induced by glutamate. L(omega)-N-nitro-arginine (given i.p., i.t., i.pl. or i.c.v.) prevented the nociception and paw oedema caused by glutamate, an effect that was reversed by L-arginine but not by D-arginine.
2.BDNF-endocannabinoid interactions at neocortical inhibitory synapses require phospholipase C signaling.
Zhao L;Levine ES J Neurophysiol. 2014 Mar;111(5):1008-15. doi: 10.1152/jn.00554.2013. Epub 2013 Dec 11.
Endogenous cannabinoids (endocannabinoids) and neurotrophins, particularly brain-derived neurotrophic factor (BDNF), are potent synaptic modulators that are expressed throughout the forebrain and play critical roles in many behavioral processes. Although the effects of BDNF at excitatory synapses have been well characterized, the mechanisms of action of BDNF at inhibitory synapses are not well understood. Previously we have found that BDNF suppresses presynaptic GABA release in layer 2/3 of the neocortex via postsynaptic tropomyosin-related kinase receptor B (trkB) receptor-induced release of endocannabinoids. To examine the intracellular signaling pathways that underlie this effect, we used pharmacological approaches and whole cell patch-clamp techniques in layer 2/3 pyramidal neurons of somatosensory cortex in brain slices from juvenile Swiss CD1 mice. Our results indicated that phospholipase Cγ (PLCγ) is involved in the CB1 receptor-mediated synaptic effect of BDNF, because the BDNF effect was blocked in the presence of the broad-spectrum PLC inhibitors U-73122 and edelfosine, whereas the inactive analog U-73343 did not alter the suppressive effect of BDNF at inhibitory synapses.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related mGluR Products


CAS 195209-04-2 ACPT-II

ACPT-II
(CAS: 195209-04-2)

ACPT-II has been found to be a mGluR antagonist and could probably exhibit neuroprotective effects.

CAS 1431980-60-7 TASP 0433864

TASP 0433864
(CAS: 1431980-60-7)

TASP 0433864 is a selective and positive allosteric modulator of mGlu2 receptor (EC50 = 199 and 206 nM for human and rat receptors, respectively) with no agonis...

CAS 1263273-14-8 (1R,2S)-VU0155041

(1R,2S)-VU0155041
(CAS: 1263273-14-8)

(1R,2S)-VU0155041 is a partial mGluR4-positive allosteric modulator (EC50= 2.35 μM) that dependently attenuated hyperalgesia in neuropathic pain model rats.

CAS 1216398-09-2 YM 298198 hydrochloride

YM 298198 hydrochloride
(CAS: 1216398-09-2)

YM 298198 hydrochloride is a non-competitive and high affinity antagonist at mGlu1 receptors (Ki = 19 nM). YM 298198 is inactive at other mGlu receptor subtypes...

CAS 407-41-0 O-Phospho-L-serine

O-Phospho-L-serine
(CAS: 407-41-0)

O-Phospho-L-serine, a molecule which resembles phosphatidylserine head group, is an agonist of the group III metabotropic glutamate receptors mGluR4a and mGluR6...

CAS 1254977-87-1 JNJ-42153605

JNJ-42153605
(CAS: 1254977-87-1)

JNJ-42153605 is a selective positive allosteric modulator of the metabotropic glutamate 2 (mGlu2) receptor (EC50= 17 Nm) with an acceptable pharmacokinetic prof...

CAS 219911-35-0 MPEP Hydrochloride

MPEP Hydrochloride
(CAS: 219911-35-0)

Potent and selective antagonist for metabotropic glutamate receptor subtype 5 (mGluR5); Systemically active in vivo.

CAS 1290628-31-7 AZ 12216052

AZ 12216052
(CAS: 1290628-31-7)

AZ 12216052 is a positive allosteric modulator of mGluR8. It reduced measures of anxiety in wild-type male mice and is used as a therapeutic target for anxiety ...

Chemical Structure

CAS 170846-89-6 E4CPG

Quick Inquiry

Verification code

Featured Items